Estimates Revisions Protara Therapeutics, Inc.
Stocks
TARA
US74365U1079
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
15:27:32 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 3.865 USD | -0.64% |
|
-2.03% | -27.58% |
| 08-11 | Protara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Protara Therapeutics CMO Leonardo Viana Nicacio Resigns | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- TARA Stock
- Consensus Protara Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
